K Pharma,Inc. (4896.T)

JPY 632.0

(-1.25%)

EBITDA Summary of K Pharma,Inc.

  • K Pharma,Inc.'s latest annual EBITDA in 2023 was 366.05 Million JPY , up 226.88% from previous year.
  • K Pharma,Inc.'s latest quarterly EBITDA in 2024 Q2 was -192.7 Million JPY , up 15.73% from previous quarter.
  • K Pharma,Inc. reported an annual EBITDA of -322.47 Million JPY in 2022, down -58.81% from previous year.
  • K Pharma,Inc. reported an annual EBITDA of -222.31 Million JPY in 2021, down 0.0% from previous year.
  • K Pharma,Inc. reported a quarterly EBITDA of -228.68 Million JPY for 2024 Q1, down -59.63% from previous quarter.
  • K Pharma,Inc. reported a quarterly EBITDA of -135.27 Million JPY for 2023 Q3, down 0.0% from previous quarter.

Annual EBITDA Chart of K Pharma,Inc. (2023 - 2021)

Historical Annual EBITDA of K Pharma,Inc. (2023 - 2021)

Year EBITDA EBITDA Growth
2023 366.05 Million JPY 226.88%
2022 -322.47 Million JPY -58.81%
2021 -222.31 Million JPY 0.0%

Peer EBITDA Comparison of K Pharma,Inc.

Name EBITDA EBITDA Difference
KOHJIN BIO CO LTD 958.1 Million JPY 61.793%
PRISM BioLab Co.,LTD -488.13 Million JPY 174.992%
GNI Group Ltd. 14.48 Billion JPY 97.474%
Linical Co., Ltd. 1.24 Billion JPY 70.65%
Trans Genic Inc. 240.95 Million JPY -51.922%
MEDINET Co., Ltd. -1.35 Billion JPY 126.998%
Soiken Holdings Inc. -583.2 Million JPY 162.767%
Cytori Cell Research Institute, Inc. -603.09 Million JPY 160.697%
AnGes, Inc. -8.86 Billion JPY 104.132%
OncoTherapy Science, Inc. -1.28 Billion JPY 128.476%
Nxera Pharma Co., Ltd. -7.39 Billion JPY 104.947%
Immuno-Biological Laboratories Co., Ltd. 128.1 Million JPY -185.744%
NanoCarrier Co., Ltd. -863 Million JPY 142.417%
Carna Biosciences, Inc. -1.09 Billion JPY 133.528%
CanBas Co., Ltd. 53.65 Million JPY -582.295%
D. Western Therapeutics Institute, Inc. -775.59 Million JPY 147.197%
RaQualia Pharma Inc. -111.8 Million JPY 427.419%
Chiome Bioscience Inc. -1.21 Billion JPY 130.209%
Kidswell Bio Corporation -1.38 Billion JPY 126.51%
PeptiDream Inc. 7.37 Billion JPY 95.037%
Oncolys BioPharma Inc. -1.92 Billion JPY 118.97%
Ribomic Inc. -1.01 Billion JPY 136.153%
SanBio Company Limited -4.52 Billion JPY 108.09%
Healios K.K. -3 Billion JPY 112.174%
BrightPath Biotherapeutics Co., Ltd. -1.16 Billion JPY 131.4%
Kubota Pharmaceutical Holdings Co., Ltd. -1.39 Billion JPY 126.277%
Delta-Fly Pharma, Inc. -1.4 Billion JPY 126.11%
StemRIM -2.03 Billion JPY 118.015%
CellSource Co., Ltd. 1.3 Billion JPY 71.98%
FunPep Company Limited -952 Million JPY 138.451%
Kringle Pharma, Inc. -888.76 Million JPY 141.187%
Stella Pharma Corporation -723.85 Million JPY 150.571%
TMS Co., Ltd. -937 Million JPY 139.067%
Noile-Immune Biotech Inc. -775.39 Million JPY 147.209%
Cuorips Inc. -518 Million JPY 170.668%
Takara Bio Inc. 8.02 Billion JPY 95.438%
ReproCELL Incorporated 8.24 Million JPY -4339.757%
PhoenixBio Co., Ltd. 87.93 Million JPY -316.268%
StemCell Institute Inc. 534.35 Million JPY 31.495%
Japan Tissue Engineering Co., Ltd. 244.81 Million JPY -49.525%
CellSeed Inc. -836.51 Million JPY 143.76%